We constructed a series of novel optical sensors for determination of broad-range pH based on a single fluorophore and multi-ionophores with different pK(a) values. These optical sensors use photoinduced electron transfer (PET) as the signal transduction and follow the design concept of "fluorophore-spacer-receptor (ionophore)" which employs 4-amino-1,8-naphthalimide as the single fluorophore, ethyl moiety as the spacer, and a series of phenols and anilines as the receptors. Key to the successful development of this sensor system is that coupling the receptors with six different pK(a) values with a single fluorophore produces the correct optical properties. This rational design affords a series of optical pH sensors with unique fluorescence property and accurately tunable pH measurement ranging from 1 to 14 pH units. Because of covalent immobilization of the indicators, these sensors demonstrate excellent stability, adequate reversibility, and satisfactory dynamic range up to full pH ranges (pH 1-14).

No abstract

A series of bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines was synthesized. Some of these analogues show high affinity and excellent selectivity for adenosine A(2a) receptor versus the adenosine A(1) receptor. Structure-activity-relationship (SAR) studies based on octahydropyrrolo[1,2-a]pyrazine and octahydropyrido[1,2-a]pyrazine with various capping groups are reported. Among these analogues, the most potent and selective A(2a) antagonist 26 h has a K(i) value of 0.2 nM and is 16 500-fold selective with respect to the A(1) receptor. Among a number of compounds tested, compounds 21a and 21c exhibited significantly improved metabolic stability. Compounds 21a, 21c, and 18a showed good oral efficacy in rodent catalepsy models of Parkinson's disease.

No abstract

Adipocytes contain adenosine receptors, termed Al receptors, which inhibit lipolysis by decreasing adenylate cyclase activity. The inhibition of lipolysis by adenosine agonists in vivo acutely suppresses the plasma concentrations of free fatty acids (FFA) and triglycerides. We have found that infusions of the adenosine receptor agonist phenylisopropyladenosine (PIA) initially decreases plasma FFA concentrations; however, with prolonged exposure (6 d), rats become very tolerant to the effects of the drug. Adipocytes isolated from epididymal fat pads from PIAinfused rats have altered lipolytic responses. When lipolysis is stimulated with a relatively high concentration of isoproterenol (10-' M), PIA does not inhibit lipolysis in adipocytes from the infused animals. However, PIA inhibits isoproterenol-stimulated cyclic AMP (cAMP) accumulation in adipocytes from the infused rats although with decreased sensitivity compared with controls. The explanation for the impaired antilipolytic effect appears to be due to the fact that isoproterenol-stimulated cAMP accumulation is markedly increased in cells from infused rats. Indeed, basal lipolysis and lipolysis stimulated with lower concentrations of isoproterenol (10-9, 10-8 M) are effectively inhibited by PIA. cAMP accumulation is greatly increased in adipocytes from infused rats when stimulated by isoproterenol, ACTH, and forskolin. The results have some striking analogies to changes induced in nerve cells by prolonged exposure to narcotics. These data suggest that tolerance to PIA develops in adipocytes as a consequence of enhanced cAMP accumulation.